Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques; Biomedicines; Vol. 9, iss. 7

Библиографические подробности
Источник:Biomedicines
Vol. 9, iss. 7.— 2021.— [802, 15 p.]
Автор-организация: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
Другие авторы: Shamil Ak. Akhmedov, Afanasjev S. A. Sergey Aleksandrovich, Trusova M. E. Marina Evgenievna, Postnikov P. S. Pavel Sergeevich, Rogovskaya Yu. V. Yuliya Viktorovna, Grakova E. V. Elena Viktorovna, Kopeva K. Kristina, Paz R. C. Rosa Carreon, Balakin S. Sascha, Wiesmann H. P. Hans Peter, Jorg O. Opitz, Kruppke B. Benjamin, Beshchasna N. Natalia, Popov S. V. Sergey
Примечания:Title screen
Atherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbon-coated iron nanoparticles (Fe@C NPs) were produced by gas-phase synthesis and modified with organic functional groups of a lipophilic nature. Modified and non-modified Fe@C NPs, immobilized with polycaprolactone on stainless steel, showed high cytocompatibility in human endothelial cell culture. Furthermore, after ex vivo treatment of native atherosclerotic plaques obtained during open carotid endarterectomy surgery, Fe@C NPs penetrated the inner structures and caused structural changes of atherosclerotic plaques, depending on the period of implantation in Wistar rats, serving as a natural bioreactor. The high biocompatibility of the Fe@C NPs shows great potential in the treatment of atherosclerosis disease as an active substance of stent coatings to prevent restenosis and the formation of atherosclerotic plaques.
Язык:английский
Опубликовано: 2021
Предметы:
Online-ссылка:https://doi.org/10.3390/biomedicines9070802
Формат: Электронный ресурс Статья
Запись в KOHA:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=666370

MARC

LEADER 00000naa0a2200000 4500
001 666370
005 20250522132349.0
035 |a (RuTPU)RU\TPU\network\37574 
035 |a RU\TPU\network\37573 
090 |a 666370 
100 |a 20211220d2021 k||y0rusy50 ba 
101 0 |a eng 
102 |a CH 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques  |f Ak. Shamil, S. A. Afanasjev, M. E. Trusova [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 33 tit.] 
330 |a Atherosclerosis, a systematic degenerative disease related to the buildup of plaques in human vessels, remains the major cause of morbidity in the field of cardiovascular health problems, which are the number one cause of death globally. Novel atheroprotective HDL-mimicking chemically modified carbon-coated iron nanoparticles (Fe@C NPs) were produced by gas-phase synthesis and modified with organic functional groups of a lipophilic nature. Modified and non-modified Fe@C NPs, immobilized with polycaprolactone on stainless steel, showed high cytocompatibility in human endothelial cell culture. Furthermore, after ex vivo treatment of native atherosclerotic plaques obtained during open carotid endarterectomy surgery, Fe@C NPs penetrated the inner structures and caused structural changes of atherosclerotic plaques, depending on the period of implantation in Wistar rats, serving as a natural bioreactor. The high biocompatibility of the Fe@C NPs shows great potential in the treatment of atherosclerosis disease as an active substance of stent coatings to prevent restenosis and the formation of atherosclerotic plaques. 
461 |t Biomedicines 
463 |t Vol. 9, iss. 7  |v [802, 15 p.]  |d 2021 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a atherosclerosis 
610 1 |a high density lipoprotein 
610 1 |a chemically modified carbon-coated iron nanoparticle 
610 1 |a reverse cholesterol transport 
610 1 |a macrophage 
610 1 |a coronary stent 
610 1 |a атеросклероз 
610 1 |a наночастицы 
610 1 |a железо 
610 1 |a холестерин 
610 1 |a углеродные покрытия 
610 1 |a стенты 
701 1 |a Shamil  |b Ak.  |g Akhmedov 
701 1 |a Afanasjev  |b S. A.  |g Sergey Aleksandrovich 
701 1 |a Trusova  |b M. E.  |c organic chemist  |c Associate professor of Tomsk Polytechnic University, Candidate of chemical sciences  |f 1982-  |g Marina Evgenievna  |3 (RuTPU)RU\TPU\pers\31823  |9 15918 
701 1 |a Postnikov  |b P. S.  |c organic chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of chemical sciences  |f 1984-  |g Pavel Sergeevich  |3 (RuTPU)RU\TPU\pers\31287  |9 15465 
701 1 |a Rogovskaya  |b Yu. V.  |g Yuliya Viktorovna 
701 1 |a Grakova  |b E. V.  |g Elena Viktorovna 
701 1 |a Kopeva  |b K.  |g Kristina 
701 1 |a Paz  |b R. C.  |g Rosa Carreon 
701 1 |a Balakin  |b S.  |g Sascha 
701 1 |a Wiesmann  |b H. P.  |g Hans Peter 
701 1 |a Jorg  |b O.  |g Opitz 
701 1 |a Kruppke  |b B.  |g Benjamin 
701 1 |a Beshchasna  |b N.  |g Natalia 
701 1 |a Popov  |b S. V.  |g Sergey 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 2 |a RU  |b 63413507  |c 20211220  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.3390/biomedicines9070802 
942 |c CF